Skip to product information
1 of 1

BD Respiratory Test Kit BD Veritor™ Plus Analyzer and Strep/Flu Combo Infectious Disease Immunoassay Influenza A + B / Strep A Test Nasal Swab / Nasopharyngeal Swab / Throat Swab Sample 90 Tests CLIA Waived - Each - 256080-EA

BD Respiratory Test Kit BD Veritor™ Plus Analyzer and Strep/Flu Combo Infectious Disease Immunoassay Influenza A + B / Strep A Test Nasal Swab / Nasopharyngeal Swab / Throat Swab Sample 90 Tests CLIA Waived - Each - 256080-EA

Regular price $1,156.99
Sale price $1,156.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

BD Respiratory Test Kit BD Veritor™ Plus Analyzer and Strep/Flu Combo Infectious Disease Immunoas...

Item Id 1087681
MF Id# 256080
Brand BD Veritor™ Plus Analyzer and Strep/Flu Combo
Manufacturer BD
Country of Origin Unknown
Application Respiratory Test Kit
CLIA Classification CLIA Waived
CLIA Classified CLIA Waived
Contents 1 BD Veritor™ Plus Analyzer, Influenza Immunoassay Kit with (30) Tests, (2) Strep A Immunoassay Kits with (30) Tests per Kit
For Use With For BD Veritor™ Analyzer
HCPCS U0002 (Disclaimer)
Number of Tests 90 Tests
Product Dating McKesson Acceptable Dating: we will ship >= 30 days
Purchase Program Type Promotion
Reading Type Machine Read
Sample Type Nasal Swab / Nasopharyngeal Swab / Throat Swab Sample
Specialty Immunoassay
Test Format Test Device Format
Test Name Influenza A + B / Strep A Test
Test Type Infectious Disease Immunoassay
Time to Results 8 to 10 Minute Results
UNSPSC Code 41116129

Features

  • Combo* Immunoassay Analyzer: Veritor Plus™ Analyzer with 1 Influenza and 2 Strep A Immunoassays
  • Provides objective, lab-quality immunoassay test results for healthcare providers and laboratorians in physician offices, clinics, hospitals, IDNs and more within minutes
  • Analyzer allows for rapid detection of infectious diseases, including SARS-CoV-2, influenza A and B, respiratory syncytial virus (RSV) and group A strep, while patients are still on site
  • The system streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation
  • Offers improved traceability by scanning three different identifiers (operator ID, specimen ID and test kit/lot) that can be locally recorded, printed or downloaded
About your query!
Recently Viewed